Santaris Can't Skirt Infringement Claim In Isis Patent Row

Law360, Los Angeles (February 27, 2014, 8:24 PM EST) -- A California federal judge on Thursday refused to let Santaris Pharma A/S Corp. off the hook in Isis Pharmaceuticals Inc.'s infringement suit accusing Santaris of leveraging Isis' patented drug discovery development platform to sign multimillion-dollar development deals, saying Santaris isn’t protected by a safe harbor statute.

Carlsbad, Calif.-based Isis is accusing the Danish pharmaceutical developer of infringing its patents by offering to sell certain drug discovery development services to several major U.S. pharmaceutical companies. In September 2012, U.S. District Judge Barry T. Moskowitz denied a summary...
To view the full article, register now.